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Abstract
This cross-sectional study (N = 4,144) compared three longitudinal dynatypes (Maintainers,
Relapsers, and Stable Smokers) of smokers on baseline demographics, stage, addiction severity,
and transtheoretical model effort effect variables. There were significant small-to-medium-sized
differences between the Stable Smokers and the other two groups on stage, severity, and effort
effect variables in both treatment and control groups. There were few significant, very small
differences on baseline effort variables between Maintainers and Relapsers in the control, but not
the treatment group. The ability to identify Stable Smokers at baseline could permit enhanced
tailored treatments that could improve population cessation rates.

Keywords
smoking cessation; maintenance; relapse; stages of change; addiction severity; transtheoretical
model; processes of change; pros and cons; self-efficacy
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INTRODUCTION
Most smoking cessation research has focused on the efficacy of alternative interventions
with samples selected to be most ready to quit (e.g., Fiore et al., 1996, 2000; Zhu et al.,
1996). As the field increasingly moves toward more population-based interventions, the full
range of readiness to quit among current smokers (Velicer et al., 1995) becomes more
relevant. Efficacy trials have led us to focus primarily on the transition from smoker to
quitter, with relapsers often viewed as treatment failures. Considerable research has focused
on predictors of successful cessation. Important predictors include addiction severity
variables such as number of cigarettes smoked and time to first cigarette (e.g., Farkas et al.,
1996; Velicer, Redding, Sun, & Prochaska, 2007), demographics, such as age and education
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(National Cancer Institute, 2000; Velicer et al., 2007), and stage of change variables
(Prochaska, Velicer, Prochaska, & Johnson, 2004; Velicer et al., 2007). In order to better
serve the full population of smokers, better understanding of dynamic variables that could
differentiate those who quit successfully (Maintainers) from those who relapse (Relapsers),
and those who least likely try to quit at all (Stable Smokers) could help us improve smoking
cessation interventions.
One way to increase our understanding of how change occurs is to study different patterns of
change over time. This study compared three groups of smokers on the basis of their distinct
patterns of change over time: those who did not quit at any of the six-month follow-ups over
a 24-month period (Stable Smokers), those who did quit at one of the six-month follow-ups
and at each subsequent follow-up (Maintainers), and those who did quit at one of the six
month follow-ups but had relapsed by the 24-month follow-up (Relapsers). This study
applied an exploratory data analysis methodology called dynamic typology that groups
participants by their pattern of changes over time (Norman, Velicer, Fava, & Prochaska,
1998; Prochaska, Velicer, DiClemente, Guadagnoli, & Rossi, 1991). These three dynatype
groups were compared on baseline variables for both treatment and control groups.
Comparing these dynatypes on baseline variables was designed to determine whether these
groups could be differentiated at baseline and then to provide basic knowledge that could be
used to improve cessation treatments.
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These same three dynatypes (Maintainers, Relapsers, and Stable Smokers) were examined in
a representative sample of smokers (Sun, Prochaska, Velicer, & Laforge, 2007). The
dynatypes were compared on their use of 14 principles and processes of change over a 24month period and clear differences were found. The Stable Smokers who were not abstinent
at any of the six-month follow-ups were the most different from the other two groups. They
made the poorest efforts at each assessment and almost all of the change variables showed
little change in effort over time. One conclusion was that a treatment breakthrough from
25% to 30% population cessation would be more likely to emerge from more effective
interventions for the Stable Smokers, the largest group, than for the Relapsers, the smallest
group. To achieve a 5% increase in overall quit rates would require preventing relapse with
78% of the Relapsers, which is not feasible. The same increase in quit rates could be
achieved by helping only about 7% of the Stable Smokers to quit, which may be feasible.
But first it needs to be determined whether the Stable Smokers can be differentiated from
other dynatypes at baseline. In the present study, these same three dynatypes in both the
treatment and control groups were compared on baseline variables representing
demographic, stage, addiction severity, and transtheoretical model (TTM) effort effects.
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In another longitudinal study (Velicer et al., 2007), several of these effects (demographics,
stage, and addiction severity) were assessed at baseline and used to predict successful
quitting at 24 months within the treatment group only. The strongest predictors of outcomes
over time included both severity variables and stages of change. There were also small
demographic effects (education and age) on long-term quitting. Effort effects evaluating
TTM variables, such as decision-making, temptations, and processes of change, were not
examined in this study. Also, none of these effects were evaluated in the control group. This
study will address each of these gaps by evaluating all four effects (demographic, stage,
severity, and effort) in both treatment and control groups.
The present study draws from these two recent studies to determine whether baseline
variables representing demographics, stage, severity, and TTM effort effects can
differentiate the three dynatypes of Maintainers, Relapsers, and Stable Smokers. In the study
by Velicer et al. (2007), only two outcome groups were compared, those who were
successful at 24 months and those who were not. Such grouping is the norm in outcome
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studies, but the other dynatype study (Sun et al., 2007) found that the Relapsers and Stable
Smokers followed very different pathways over time, with the Stable Smokers making the
poorest efforts. The question arises whether the Relapser and the Stable Smoker dynatypes,
in particular, can be differentiated at baseline, which could allow interventions to improve
outcomes with these groups.

METHODS
Sample
This study began with a representative sample of 4,144 smokers proactively recruited in
Rhode Island by random digit dialing (RDD) procedures (Fava, Velicer, & Prochaska,
1995). Even though this was an RDD sample, 55% were female. The mean age was about 40
years, and a little over 50% were married. The vast majority were non-Hispanic Caucasians.
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Of these smokers, 42.1% were in the precontemplation stage and were not intending to quit
smoking in the next six months, 40.3% were in the contemplation stage and were intending
to quit in the next six months, and 17.6% were in the preparation stage and were intending to
quit in the next month and had quit for at least 24 hr in the past year (Fava et al., 1995).
They smoked a mean of 20.6 cigarettes per day. About one-third of the smokers (n = 1358)
were randomly assigned to the treatment group and about two-thirds to the assessment-only
group (n=2786). The treatment group was mailed tailored expert system intervention
materials at baseline, three, and six months. All subjects were proactively assessed at sixmonth intervals for 24 months. Treatment outcomes and other details of this study are
reported in the study by Prochaska, Velicer, Fava, Rossi, and Tsoh (2001).
Over the 24 months of the study, 3,163 (76.3%) of the participants were Stable Smokers,
705 (17%) were Maintainers, and 276 (6.6%) were Relapsers. Table 1 presents the
demographics for these three dynatypes in both the treatment and control groups. Treatment
and control groups will be analyzed separately throughout so that different predictors can
emerge.

MEASURES
All variables were assessed by self-report during the baseline phone survey.
Demographics

NIH-PA Author Manuscript

Demographic variables included Age (“What is your current age?”) and Education (“How
many years of school have you completed?”) that involved open-ended responses. Gender,
Race, and Ethnicity involved multiple-choice responses with the following categories:
gender (male/female), Hispanic or Latino (yes/no), and race (Asian/black or AfricanAmerican/White/Native Hawaiian, or Other Pacific Islander/American Indian or Alaskan
Native).
Severity
Severity variables reflect the degree of addiction and included the number of cigarettes
smoked and time to first cigarette, two main parts of the Fagerstrom index (Heatherton,
Kozlowski, Frecker, & Fagerstrom, 1991).
Stages of Change
A three-item algorithm was used with precontemplation defined as not intending to quit
smoking in the next six months, contemplation defined as intending to quit in the next six
months, and preparation defined as intending to quit in the next month and having made a
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quit attempt in the past 12 months. This algorithm has been found to have strong predictive
validity over 6 (DiClemente et al., 1991), 12, 18, and 24 months (Prochaska et al., 2004;
Velicer et al., 2007).
Decisional Balance
The “Decisional Balance” scale assesses cognitive and motivational aspects of smoking
cessation decision-making (Velicer, DiClemente, Prochaska, & Brandenberg, 1985), with
two subscales labeled the Pros and the Cons of smoking. This TTM construct also reflects
effort effects (Blissmer et al., 2010). Subjects responded using a five-point Likert scale of
importance (1 = not at all important; 3 = somewhat important; 5 = very important). For this
study, a six-item short form (Fava, Rossi, Velicer, & Prochaska, 1991; Ward, Velicer, Rossi,
Fava, & Prochaska, 2004) was used. Correlations between the short form and the original
length scales were .88 for both Pros and Cons.
Processes of Change
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The processes are strategies that individuals (e.g., interventionists or self-changers) use to
modify problem behaviors. The Processes of Change Questionnaire (Prochaska, Velicer,
DiClemente, & Fava, 1988) measures 10 processes of change in a statistically well-defined
and reliable manner. Subjects responded using a five-point Likert scale of frequency of use
in the past month (1 = never; 3 = occasionally; 5 = repeatedly). These TTM variables reflect
effort effects (Blissmer et al., 2010). Confirmatory factor analysis supported the 10-process
measurement model (Prochaska, et al., 1988), with two higher order factors of five processes
each labeled: experiential and behavioral. The 20-item short-form version (Fava et al., 1991)
of this measure was used. Alpha coefficients were good to excellent for two-item scales and
ranged from .67 to .90 with a mean of .80. Correlations between the short-form scales and
the original scales ranged from .87 to .96.
Situational Temptation

NIH-PA Author Manuscript

The Situational Temptation scale (DiClemente, Prochaska, & Gibertini, 1985: Velicer,
DiClemente, Rossi, & Prochaska, 1990) measures cue strength and parallels a measure of
cessation self-efficacy. Psychometric analysis revealed a hierarchical structure with three
first-order factors: Positive Social, Negative Affect, and Habit Addictive (Velicer et al.,
1990). This TTM construct reflects effort effects (Blissmer et al., 2010). Subjects responded
using a five-point Likert scale of temptations to smoke (1 = not at all tempted; 3 = somewhat
tempted; 5 = very tempted). To reduce response burden, a nine-item short form (Fava et al.,
1991) was used. Correlations between the three-item short form and the original length
scales were .97 for the Positive Social subscale, .98 for the Negative Affect subscale, and .
91 for the Habit Addictive subscale.
Dynatype Groups
Because all participants smoked at baseline, the three dynatypes were formed on the basis of
the patterns of change in smoking from baseline to 6-, 12-, 18-, and 24-month follow-ups
(Sun et al., 2007). Maintainers were defined as participants who had quit at any single
assessment and all subsequent assessments or who had quit at the last assessment (n = 705;
17%). Stable smokers were defined as those who did not quit at any of the five assessments
(n = 3,163; 76.3%). Relapsers included participants who did quit at any assessment and later
reported smoking again (n = 276; 6.6%).
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Table 1 shows the relationships between baseline demographic variables and dynatype
groups in both treatment and control groups.
There were no significant differences between the three dynatypes in either the treatment or
control condition for gender, race, or ethnicity. There was a significant difference in the
control group for age, with the Maintainers having significantly more adults over the age of
50 years (31.26%) than either Relapsers (21.65%, h=0.219) or the Stable Smokers (23.87%,
h = 0.166). The effect size indicator Cohen’s h represents the standardized difference
between proportions (Cohen, 1988; Rossi, 1985). Its interpretation is exactly analogous to
that of Cohen’s d (h = 0.20 = small effect size; h = 0.50 = medium effect size; h = 0.80 =
large effect size). There was a significant difference in treatment group for education, with
the Stable Smoker dynatype having significantly more participants with less than a high
school education (17.12%) compared with the Maintainers (11.42%, h=0.164) or the
Relapsers (8.54%, h = 0.260).
Table 2 shows the baseline addiction and stage differences with effect sizes between
dynatype groups for both control and treatment groups.
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Table 2 indicates that on the two addiction variables, there were significant differences in
both treatment and control groups between the Stable Smokers and the other two groups,
with the Stable Smokers showing more severe addiction levels on both variables. Effect
sizes for both addiction variables were in the small-to-medium range and were comparable
between treatment and control groups. Both the Maintainers and the Relapsers had longer
time to first cigarette than the Stable Smokers. The Stable Smokers smoked about four more
cigarettes per day than both other groups. There were no significant differences between the
Maintainers and Relapsers on either addiction variable in either treatment or control group.
Table 2 also shows that on the stage variable, there were significant differences in both the
treatment and control groups, with the Stable Smokers having more smokers in the
precontemplation stage and fewer in the preparation stage. There were no significant
differences between the Maintainers and Relapsers on any of the three stages in either the
control or treatment group. Comparing stage distributions in the Stable Smokers versus the
other two groups combined, the effect sizes for each stage are given in Table 2. Effect sizes
for precontemplation and preparation were in the small-to-medium range, while effect sizes
for contemplation were quite small. Effect sizes by stage were comparable in treatment and
control groups.
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Table 3 shows the baseline TTM effort variable differences with effect sizes between
dynatype groups for both control and treatment groups. Because most of these variables are
used to tailor expert system feedback (Redding et al., 1999; Velicer & Prochaska, 1999;
Velicer et al., 1993), differences on these variables could have important implications for
tailored treatments to better serve the Stable Smoker group. These variables reflect baseline
effort on decision-making, affective, and behavioral skill variables that have demonstrated
relationships to subsequent outcomes.
In a series of planned comparisons, significant differences in the control group were found
between the Stable Smokers and the other two dynatypes on all of the TTM variables except
social liberation. With 17 of the 18 TTM variables listed, the Stable Smokers were
significantly worse off at baseline, with higher levels of addiction and temptations, higher
pros of smoking, lower cons of smoking, and less process use. In addition, in the control
group only, the Relapsers were using dramatic relief (d = .17), self-liberation (d = .15), and
the total experiential (d = .15) and behavioral (d = .12) processes significantly more than the
Subst Use Misuse. Author manuscript; available in PMC 2011 October 1.
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Maintainers. In the treatment group, these results comparing the Stable Smokers with the
other two dynatypes groups were replicated on 10 of the 18 listed variables, with no
significant differences observed at baseline on cons of smoking, positive social temptations,
negative affect temptations, consciousness raising, dramatic relief, environmental
reevaluation, social liberation, and reinforcement management.
Examining Tables 2 and 3 reveals many significant small and small-to-medium effect sizes
reflecting baseline differences between the Stable Smokers and the other two dynatype
groups, including addiction severity, stages of change, and effort effect variables. The effect
sizes generally ranged from about .2 to .4 standard deviation (SD). Effect sizes were
generally comparable in both control and treatment groups.

DISCUSSION
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These results show that in the control group, the Stable Smokers were consistently
differentiated at baseline from the Maintainers and Relapsers by addiction severity, stage,
and effort variables. A comparable pattern of results was replicated in the treatment group.
In fact, the replication of these severity, stage, and effort effects across treatment and control
groups is an important finding. TTM-tailored interventions were developed in part by
mimicking successful patterns of change among self-changers, and so, comparable
predictors of outcome groups across treatment and control groups both reflect and support
this approach. Treatment and control groups are changing in the same ways. Of course,
treatment and control groups change at different rates (Prochaska et al., 2001); however, the
variables associated with change are comparable. Also, in the control group only, the
Relapsers were using four effort variables (dramatic relief, self-liberation, total experiential
process, and behavioral process sums) significantly more than the Maintainers, although
these effects were fairly small. These results have important implications for enhancing
interventions.
First, most smoking cessation research, by examining predictors of successful outcome,
winds up grouping together Stable Smokers and Relapsers as treatment failures. In contrast,
this research indicates that at baseline, the Relapsers and the Maintainers were much more
similar and the Stable Smokers were the most different from the other two groups. These
results indicate that Stable Smokers can be differentiated at baseline and therefore could be
treated differently in interventions.
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Second, the Stable Smokers differ on dynamic variables, such as addiction severity, stage,
and other TTM variables, which are subject to change much more than on static variables,
such as demographics, which are not subject to intentional change. Third, although the
Stable Smokers were worse off at baseline on these dynamic variables, the magnitude of
these differences was in the relatively small range of .2–.4 SD. With TTM-tailored
interventions, a typical goal is to produce improvements in the .3–.4 SD range on these
dynamic variables (Prochaska, Velicer, Guadagnoli, Rossi, & DiClemente, 1991).
One strategy would be to identify those who are likely to remain Stable Smokers and tailor
interventions to their special needs and challenges. The long-term goal would be to help this
stable group take action over time. The immediate intervention goal would be to increase
their effective use of the TTM effort variables by only .2–.4 SD, which should be
achievable. Such improvement would help this group to have a pattern that would be more
comparable to the Maintainers and the Relapsers. The assumption is that the more the Stable
Smokers model early in treatment the groups who took action over time, the more likely this
group would also take action over time. Some of them would relapse, but if they follow the
pattern described in this study, many who took action could become Maintainers.
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Another strategy would be to apply interventions with the Stable Smokers that have been
found to produce significant effects in populations of unmotivated smokers. Carpenter,
Hughes, Solomon, and Callas (2004) found with a large sample of smokers in
precontemplation and contemplation that 23% were abstinent at six months following five
sessions of motivational interviewing delivered by telephone. This was significantly greater
than 4% in the control group. They also found that in a third treatment, smoking reduction
counseling utilizing nicotine replacement therapy (NRT) produced 18% abstinence at six
months (Carpenter et al., 2004).
The best strategy is likely to be a combination of tailored communications that improve the
use of TTM change principles and processes, and motivational and biological treatments that
enhance motivation and reduce the severity of addiction simultaneously. Such combinations
would counter the view of some like Farkas and colleagues (1996), Abrams, Herzog,
Emmons, and Linnan (2000), and West (2005) who pit TTM variables against addiction
variables rather than finding creative ways to integrate these variables theoretically and
practically (Noar, Benac, & Harris, 2007; Shiffman, 1996; Velicer et al., 2007).
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This study had some limitations. Dynatypes were defined broadly (e.g., all relapsers).
Examining dynatype groups in a more fine-grained manner (relapsing at one, two, or three
timepoints) in future studies may provide additional useful information. The Maintainer
group included those who quit at the last study timepoint, even though we could not verify
that quitting was sustained later. This may have reduced differences between Maintainers
and Relapsers. Follow-up timepoints were at six-month intervals. Other time intervals may
prove important in the future. This sample reflects only those who were followed
longitudinally and not study dropouts. Future examination of additional sample description,
especially resources and functional limitations, may prove useful.
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In this study, compared with the Stable Smokers, the Maintainers and Relapsers who were
further along in the stages of change were using TTM effort variables and processes of
change more effectively and reported less severe addiction levels. One interpretation of
these results is that the Maintainers and Relapsers had less severe addiction because they
were using self-change or self-control processes more to control their smoking. The
traditional view has been that lighter smokers are more successful in quitting because they
are less addicted (e.g., West, 2005). An alternative hypothesis is that lighter smokers are
more successful because they are already utilizing change processes to control their smoking
and can use these processes to further control their smoking when they take action to quit
(Rossi, Prochaska, & DiClemente, 1988). Future research needs to find ways to maximize
treatment, stage, effort, and severity effects early in treatment, over the course of treatment,
and long after treatment ends.
These results add to our concerns that population cessation breakthroughs are unlikely to
emerge from treatment enhancements for Relapsers (Sun et al., 2007). These results indicate
that in the treatment group, the Relapsers could not be differentiated from the Maintainers at
baseline. Treatment could not be tailored to the special needs and challenges of Relapsers at
the start of treatment, as it could for the Stable Smokers. Given their baseline advantages
over the Stable Smokers, it is not surprising that the Relapsers would quit during at least one
of the six-month follow-ups. But what does this group do differently over time that prevents
them from sustaining their quit attempt in the way the Maintainers do?
Across 10 processes of change and over 24 months, the Relapsers on average were using
five of the processes the most: dramatic relief, self-revaluation, environmental revaluation,
helping relationship, and self-liberation (Sun et al., 2007). In the present study, the Relapsers
in the control group were using four effort variables more than the Maintainers at baseline.

Subst Use Misuse. Author manuscript; available in PMC 2011 October 1.

Redding et al.

Page 8

NIH-PA Author Manuscript

Both the current baseline and the previous longitudinal results suggest that relapse may not
be due to these smokers failing to work hard enough. They do need to adjust their strategies,
however. Longitudinally, compared with Maintainers, Relapsers do not decrease their
reliance on self-revaluation and decision-making and do not increase their use of
counterconditioning and stimulus control (Sun et al., 2007), which would serve them better.
One promising approach would be to provide expert guidance on how they can continue to
parallel the Maintainers’ use of change principles and processes over the long-term.
The present results and the previous longitudinal data (Sun et al., 2007; Velicer et al., 2007)
support the view that there are at least two types of smokers that our current best practices
fail in population cessation trials. The group in which we most often fail is the Stable
Smokers who were not even trying to quit at any follow-up over a two-year period. This
dynatype had the most disadvantages at baseline, including more severe addiction levels,
starting in earlier stages of change, and making poorer efforts in applying change processes.
This group is likely to need more intensive treatments to help them work harder to overcome
their initial disadvantages. The Relapsers may also need more tailored treatments to help
them to work smarter. Future research needs to determine whether treating one or both of
these dynatypes differently can produce breakthroughs in population cessation rates.
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TTM

Transtheoretical model

RDD

random digit dial

CR

Consciousness Raising

DR

Dramatic Relief

ER

Environmental Reevaluation

SR

Self Reevaluation

SO

Social Liberation

HR

Helping Relationships

SC

Stimulus Control

CC

CounterConditioning

RM

Reinforcement Management

SL

Self Liberation

PC

Precontemplation

C

Contemplation

Prep

Preparation

NIH

National Institutes of Health

CDC

Centers for Disease Control and Prevention

HRSA

Health Resources and Services Administration

NHLBI

National Heart Lung & Blood Institute
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Baseline demographic differences between dynatypes for control and treatment groups
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Variable

Maintainer (N = 705)

Relapser (N = 276)

Stable Smoker (N = 3,163)

%

%

%

χ2

Age
Control group

12.08**

Less than 50 years

68.74

78.35

76.13

50+ years

31.26

21.65

23.87

Treatment group

0.26

Less than 50 years

74.02

76.83

74.56

50+ years

25.98

23.17

25.44

Gender
Control group

4.04

Male

39.69

45.88

44.65

Female

60.31

54.12

55.35

Male

44.49

48.78

44.91

Female

55.51

51.22

55.09

<12

18.18

14.43

20.74

12

39.02

41.24

41.01

13–15

26.61

30.41

25.08

16+

16.19

13.92

13.17

Treatment group

0.50

NIH-PA Author Manuscript

Education
Control group

9.33

Treatment group

13.52*

<12

11.42

8.54

17.12

12

39.76

43.90

41.68

13–15

26.77

26.83

25.83

16+

22.05

20.73

15.36

No

98.23

97.92

97.71

Yes

1.77

2.08

2.29

Hispanic
Control group

0.47

NIH-PA Author Manuscript

Treatment group

0.24

No

98.02

98.78

98.33

Yes

1.98

1.22

1.67

Race
Control group

4.28

White

96.45

95.34

94.67

Black

2.22

3.63

3.27

Asian/Pacific

0.44

0.00

0.37

American Indian/Alaskan

0.89

1.04

1.68
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Variable

Maintainer (N = 705)

Relapser (N = 276)

Stable Smoker (N = 3,163)

%

%

%

NIH-PA Author Manuscript

Treatment group

χ2
2.49

White

97.23

97.56

96.86

Black

1.19

0.00

1.47

Asian/Pacific

0.40

1.22

0.39

American Indian/Alaskan

1.19

1.22

1.28

*

p < .05,

**

p < .01.
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41.91
27.72

C

Prep

27.95
48.03
24.02

PC

C

Prep

Treatment group

30.38

PC

Control group

Smoking stage
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p < .01.

**

%

17.48 (11.06)

Treatment group

Variables

17.26 (10.12)

Control group

p < .05,

*

89.03 (131.61)

Treatment group

Cigarettes per day

89.47 (138.15)

M (SD)

Control group

Time to first cigarette

Variable

Maintainer (N = 705)

28.05

39.02

32.93

27.32

44.85

27.84

%

19.38 (11.41)

17.56 (10.33)

93.54 (129.88)

84.86 (151.14)

M (SD)

Relapser (N = 276)

14.09

40.22

45.69

15.18

38.63

46.19

%

21.16 (11.16)

21.64 (11.62)

55.51 (104.09)

53.75 (98.97)

M (SD)

Stable Smoker (N = 3,163)

38.63**

.28

.11

.35

.30

.08

.34

h

χ2

77.19**

.29

.38

.31

.31

d

11.43**

35.72**

12.15**

23.96**

F

Baseline addiction and stage differences between dynatypes for control and treatment groups
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7.04 (2.87)

Treatment group

9.26 (3.08)

Treatment group

29.12 (6.36)

Treatment group

10.34 (2.40)

Treatment group

11.07 (3.05)

Treatment group
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7.71 (2.97)

Treatment group

Control group

5.18 (2.29)

5.97 (2.06)

Treatment group

DR

5.79 (2.14)

Control group

CR

Experiential processes

7.12 (2.90)

Control group

Habit strength

11.00 (3.22)

Control group

Negative affect

10.02 (2.65)

Control group

Positive/social

28.53 (6.73)

Control group

Total

Temptations

9.12 (3.07)

Control group

Cons

6.98 (2.79)

M (SD)

Control group

Pros

Decisional balance

Variable

Maintainer (N = 705)

5.57 (2.38)

5.57 (1.96)

6.01 (2.15)

7.82 (2.98)

8.01 (2.74)

11.42 (2.94)

11.21 (3.00)

10.35 (2.80)

10.34 (2.63)

29.59 (7.10)

29.55 (6.60)

9.29 (2.83)

9.28 (2.80)

6.78 (2.60)

7.06 (2.70)

M (SD)

Relapser (N = 276)

4.97 (2.30)

5.67 (2.13)

5.65 (2.13)

8.51 (2.88)

8.51 (3.00)

11.37 (3.01)

11.43 (3.01)

10.47 (2.63)

10.48 (2.56)

30.35 (6.64)

30.42 (6.71)

8.87 (3.15)

8.68 (3.01)

7.41 (2.93)

7.46 (2.85)

M (SD)

Stable Smoker (N = 3,163)

6.82**

2.26

3.04*

9.04**

22.19**

1.07

4.06*

0.29

5.89**

3.75*

15.38**

2.11

8.29**

3.11*

6.27**

F

.14

.10

.10

.27

.29

.07

.12

.05

.14

.17

.24

.13

.18

.15

.16

d
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5.67 (2.58)

Treatment group

5.89 (2.58)

Treatment group

7.78 (2.01)

Treatment group

30.59 (7.74)

Treatment group

5.23 (2.56)

Treatment group

3.33 (2.00)

Treatment group
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4.81 (1.88)

Treatment group

Control group

6.35 (2.36)

3.96 (2.19)

Treatment group
SL

4.11 (2.44)

Control group

RM

4.74 (1.92)

Control group

CC

3.14 (1.75)

Control group

SC

5.05 (2.72)

Control group

HR

Behavioral processes

30.06 (8.23)

Control group

Experiential sum

7.44 (2.03)

Control group

SO

6.05 (2.61)

Control group

SR

5.61 (2.56)

5.28 (2.34)

Control group

ER

Treatment group

M (SD)

Maintainer (N = 705)

6.72 (2.43)

3.87 (2.30)

4.25 (2.39)

4.66 (1.83)

4.79 (2.04)

3.07 (1.62)

3.23 (1.98)

5.13 (2.60)

5.34 (2.62)

29.63 (7.93)

31.27 (8.57)

7.60 (1.87)

7.65 (2.03)

6.23 (2.59)

6.26 (2.51)

5.35 (2.57)

5.78 (2.63)

4.88 (2.21)

M (SD)

Relapser (N = 276)

5.65 (2.46)

3.86 (2.32)

3.82 (2.30)

4.44 (1.84)

4.35 (1.86)

2.87 (1.54)

2.86 (1.54)

4.73 (2.63)

4.69 (2.62)

28.84 (8.50)

28.95 (8.55)

7.49 (2.14)

7.54 (2.06)

5.54 (2.64)

5.49 (2.63)

5.22 (2.55)

5.29 (2.54)

4.92 (2.27)

M (SD)

Stable Smoker (N = 3,163)

3.18

5.41**

2.65

F

28.89**

0.19

5.24**

4.36*

11.95**

8.16**

8.92**

4.31*

7.83**

4.61*

8.81**

1.92

0.81

3.97*

14.23**
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Variable

.33

.03

.14

.18

.22

.24

.19

.18

.17

.18

.17

.11

.02

.17

.24

.15

.14

.11

d
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23.40 (7.36)
23.84 (7.34)

Treatment group

p < .01.

**

6.51 (2.49)

M (SD)

Control group

Behavioral sum

Treatment group

p < .05,

*
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Maintainer (N = 705)

23.00 (6.57)

24.33 (7.78)

6.37 (2.42)

M (SD)

Relapser (N = 276)

21.56 (7.00)

21.37 (7.09)

5.67 (2.43)

M (SD)

Stable Smoker (N = 3,163)
F

11.43**

26.61**

13.42**
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Variable

.30

.32

.32

d
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